RETRACTED: EVIDENCE OF ANCIENT HIV-1 TRANSMISSION IN THE NORTHERN EUROPE. PALAEOEPIDEMIOLOGICAL ANALYSIS

RETRACTED: EVIDENCE OF ANCIENT HIV-1 TRANSMISSION IN THE NORTHERN EUROPE. PALAEOEPIDEMIOLOGICAL ANALYSIS

RETRACTED ARTICLELongitudinal co-evolution of human beings and pathogens resulted in polymorphism of Homo sapiens. CCR5Δ32 HIV-resistance allele is the exception to the rules. Recent origin of HIV-1 in Africa contradicted with the appearance of CCR5Δ32 allele in Northern Europe in previous ages. The...

Full description

Bibliographic Details
Main Author:	V. P. Sergiev
Format:	Article
Language:	Russian
Published:	Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2022-12-01
Series:	Сеченовский вестник
Subjects:	human immunodeficiency virus origin of hiv-1 ccr5δ32 allele
Online Access:	https://www.sechenovmedj.com/jour/article/view/854

Similar Items

The hypothesis of non-African origin of human immunodeficiency virus type 1
by: V. P. Sergiev
Published: (2014-09-01)

Retraction of the article “Evidence of ancient HIV-1 transmission in the Northern Europe. Palaeoepidemiological analysis”
by: article Editorial
Published: (2022-09-01)

The frequency of allele CCR5Δ32 in a Serbian population
by: Đorđević Valentina, et al.
Published: (2013-01-01)

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells
by: Laura E. P. Huyveneers, et al.
Published: (2022-09-01)

Frequency of CCR5 Delta-32 Mutation in Human Immunodeficiency Virus (HIV)-seropositive and HIV-exposed Seronegative Individuals and in General Population of Medellin, Colombia
by: Francisco J Díaz, et al.
Published: (2000-04-01)

CCR5Δ32 and HLA allele diversity in bone marrow donors from southern Brazil
by: Bruna Kulmann-Leal, et al.
Published: (2024-07-01)

The Latitude Wise Prevalence of the CCR5-Δ32-HIV Resistance Allele in India
by: Bhatnagar I, et al.
Published: (2009-01-01)

Editorial: CCR5: A receptor at the center stage in infection
by: Joel Henrique Ellwanger, et al.
Published: (2022-10-01)

The effect of combined polymorphisms in chemokines and chemokine receptors on the clinical course of HIV-1 infection in a Brazilian population
by: Valdimara Corrêa Vieira, et al.
Published: (2011-06-01)

CCR5 genotype and plasma ß-chemokine concentration of Brazilian HIV-infected individuals
by: Mikawa A.Y., et al.
Published: (2002-01-01)

Distribution of the CCR5delta32 allele (gene variant CCR5) in Rondônia, Western Amazonian region, Brazil
by: Josileide Duarte de Farias, et al.
Published: (2012-01-01)

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
by: Hager Mohamed, et al.
Published: (2022-01-01)

Genetic factors influencing HIV infection: a review
by: Bogusz Aksak-Wąs, et al.
Published: (2022-11-01)

Pushing it back. Dating the CCR5–32 bp deletion to the Mesolithic in Sweden and its implications for the Meso\Neo transition
by: Kerstin Lidén, et al.
Published: (2006-12-01)

CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair
by: Anna J. Jasinska, et al.
Published: (2022-01-01)

Gene Therapy Targeting HIV Entry
by: Chuka Didigu, et al.
Published: (2014-03-01)

Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe
by: Stefanos Limnaios, et al.
Published: (2022-01-01)

Frequencies of CCR5-D32, CCR2-64I and SDF1-3’A mutations in Human Immunodeficiency Virus (HIV) seropositive subjects and seronegative individuals from the state of Pará in Brazilian Amazonia
by: Fernanda Andreza de Pinho Lott Carvalhaes, et al.
Published: (2005-12-01)

The Lack of the Association of the CCR5 Genotype with the Clinical Presentation and Frequency of Tick-Borne Encephalitis in the Polish Population
by: Sambor Grygorczuk, et al.
Published: (2022-03-01)

Determination of HIV Tropism in Patients with Antiretroviral Therapy Failure in Arkhangelsk Region
by: Yu. V. Ostankova, et al.
Published: (2022-10-01)

Study of Patterns and Markers of Human Immune Deficiency Virus -1 (HIV-1) Progression and Unemployment Rate among Patients from Alexandria, Egypt
by: Faika M. Ghoneim, et al.
Published: (2017-12-01)

Impact of CCR5Δ32 on the risk of infection, Staphylococcus aureus carriage, and plasma concentrations of chemokines in Danish blood donorsResearch in context
by: Khoa Manh Dinh, et al.
Published: (2024-11-01)

Δ<i>ccr5</i> Genotype Is Associated with Mild Form of Nephropathia Epidemica
by: Konstantin Kletenkov, et al.
Published: (2019-07-01)

The Ancient Origin of HIV
by: V. P. Sergiev
Published: (2023-09-01)

Bioinformatically analyzed relationships between specific human genes associated with HIV attachment
by: Vladimir S. Davydenko, et al.
Published: (2024-12-01)

Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy
by: S. Bowler, et al.
Published: (2019-09-01)

Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population
by: Munerato Patrícia, et al.
Published: (2003-01-01)

CCR2 Genetic Polymorphism And Its Potential Effect On HIV Acquisition In A Population Of Children Living In The Northern Region Of Cameroon
by: Ngoufack MN, et al.
Published: (2019-11-01)

Preventing HIV transmission through blockade of CCR5: rationale, progress and perspectives
by: Elsa Martins, et al.
Published: (2018-01-01)

Effectiveness of a Randomized Controlled Hiv-Risk-Reduction Program Field Trial with Students at Ahmadu Bello University Zaria
by: Abdulmumin, Saad
Published: (2010)

Profile of HIV subtypes in HIV/HBV- and HIV/HCV-coinfected patients in Southern Brazil
by: Valéria Miranda Avanzi, et al.

Major HIV vaccine candidates
by: Wojciech Zdziennicki, et al.
Published: (2023-05-01)

Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members
by: Elena Gonzalo-Gil, et al.
Published: (2019-04-01)

Generalized Severe Plaque Psoriasis in an HIV Positive Patient – a Challenging Treatment
by: Chiriac Anca, et al.
Published: (2017-03-01)

Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
by: Kim A. Papp, et al.
Published: (2022-04-01)

Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control
by: Anshika Jain, et al.
Published: (2024-05-01)

The life circumstances of HIV-positive women: the case of Magunje Township, Zimbabwe
by: Kambarami, Maureen Cresencia, et al.
Published: (2017-08-01)

Thirty-five years (1986–2021) of HIV/AIDS in Nigeria: bibliometric and scoping analysis
by: Henshaw Uchechi Okoroiwu, et al.
Published: (2022-12-01)

Predictors of erectile dysfunction in men living with HIV: A systematic review update
by: Mostafa Golshekan, et al.
Published: (2024-01-01)

Positivity rate, trend and associated risk factors of mother-to-child transmission of HIV among HIV-exposed infants
by: Gadissa Gutema, et al.
Published: (2023-06-01)